Characteristics of participants with recorded 6-month study visits taking hydroxyurea for 6 months or longer (N = 39)
| Characteristic . | No. (%) . | Median . | Range or IQR . |
|---|---|---|---|
| Age at enrollment, y | — | 7 | 0 to 16 (range) |
| Sex | |||
| Female | 20 (53) | — | — |
| Male | 18 (47) | — | — |
| Length of follow-up time at KCH (months) | 39 | 29 | 16-38 (range) |
| Hemoglobin since starting hydroxyurea (g/dL) | 129* | 7.4 | 6.5-8.1 (IQR) |
| Lactate dehydrogenase since starting hydroxyurea (U/L) | 108* | 664 | 525.5-769.0 (IQR) |
| Characteristic . | No. (%) . | Median . | Range or IQR . |
|---|---|---|---|
| Age at enrollment, y | — | 7 | 0 to 16 (range) |
| Sex | |||
| Female | 20 (53) | — | — |
| Male | 18 (47) | — | — |
| Length of follow-up time at KCH (months) | 39 | 29 | 16-38 (range) |
| Hemoglobin since starting hydroxyurea (g/dL) | 129* | 7.4 | 6.5-8.1 (IQR) |
| Lactate dehydrogenase since starting hydroxyurea (U/L) | 108* | 664 | 525.5-769.0 (IQR) |
IQR, interquartile range.
All laboratory results for multiple patient visits combined.